ABOUT US
A clinical research organization built around the populations others miss.
Rubix LS is a full-service clinical research and evidence generation company. We design studies, run trials, and build real-world evidence from patient populations most underrepresented in clinical research — with 25M+ integrated patient records covering the communities standard databases miss.
What We Do
We work across the full development lifecycle — from early-stage translational strategy through Phase I/II execution and federal public health research. Our teams handle protocol development, regulatory strategy, biomarker work, site management, safety monitoring, data management, and biostatistics. What ties it together is access to patient populations most organizations can't reach.
Where Evidence Gaps Show Up
When studies are designed on databases that underrepresent the patient population, the gaps show up later — in Complete Response Letters citing inadequate representation, in payer pushback on real-world applicability, and in label language that constrains commercial reach. Rubix LS works upstream of those problems.
​
-
Feasibility assessments grounded in 25M+ integrated patient records covering underrepresented populations.
-
Site network access in communities that traditional CRO networks don't reach.
-
Regulatory strategy built to hold up under FDA diversity guidance and payer scrutiny.
Access to the Populations That Matter
Standard clinical databases underrepresent the patients most affected by the diseases they're used to study. Rubix LS operates a different kind of network — mobile clinical sites, community partnerships, and a patient records infrastructure built specifically for populations the field has historically missed.
What This Looks Like in Practice
Every program Rubix LS runs generates the evidence sponsors and federal partners need to move forward with confidence — through study design that anticipates regulator and payer questions, execution that maintains retention in populations others lose, and reporting that stands up in the record.
